Multiple studies discussed today in an official press briefing at the 21st International AIDS Conference (AIDS 2016) in Durban collectively provide new insights that will help shape future HIV prevention and treatment efforts for women and girls.
18 July 2016 | AIDS 2016
In an analysis spanning several decades that included work done as recently as 2012, researchers found that women typically comprised about 11 percent of participants in trials investigating cures for HIV. Similarly, drug studies were only about 19 percent female and just 38 percent of vaccine trial subjects were women.
05 October 2015 | Reuters
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens.
22 September 2015 | Science Daily
Pregnancy could be a turning point for HIV-infected women, when they have the opportunity to manage their infection, prevent transmission to their new baby and enter a long-term pattern of maintenance of HIV care after giving birth—but most HIV-infected women aren’t getting that chance. That is the major message from a pair of new studies in Philadelphia, one published early online this month in the journal Clinical Infectious Diseases, and the other published in July in PLOS ONE.
26 August 2015 | Drexel Now
Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster.
10 June 2015 | Science Daily
Zeda Rosenberg, Chief Executive Offiver of the International Partnership for Microbicides, says: "While there is much progress to celebrate in HIV treatment and prevention, protecting women remains a major challenge. AIDS is the number-one killer of women ages 15 to 44 worldwide. Women are biologically more vulnerable to infection and face deep-rooted gender inequities that increase their risk. In sub-Saharan Africa, where the epidemic has taken the greatest toll, young women are at least twice as likely to contract HIV as young men."
26 November 2014 | Huffington Post
A global health controversy erupted this summer when the prominent scientific journal Nature ran an article entitled “HIV trial attacked.” Within, commentators squared off over whether a huge ongoing study provides suboptimal and thus unethical treatment options to mothers with HIV in the developing world.
02 October 2014 | Health Affairs (blog)
The pain of living through the loss of three children was enough to discourage Constance Mudenda from ever contemplating parenting. When she was pregnant, her greatest desire was to have a child born free of HIV, and now she will continue to mentor her daughter to ensure she is protected from acquiring HIV.
21 August 2014 | Times of Zambia
All pregnant, HIV positive women will go onto lifelong antiretroviral treatment from January, Health Minister Dr Aaron Motsoaledi announced in his health budget vote yesterday.
24 July 2014 | AllAfrica
This is the second in a three-part series of about women and Option B+ in Africa.
"Although Swazi women have better health-seeking behaviour than men, they find it hard to deal with HIV because of socio-cultural barriers, says the study. Many HIV positive married women live in a dilemma between obeying their husbands or following the advice of the health workers."
05 June 2014 | IPS